Highlights Roche Holding AG London S.E.

Equities

0TDF

US7711951043

Delayed London S.E. Other stock markets 09:31:49 2024-06-12 EDT			5-day change	1st Jan Change
34.01 ^USD	+7.19%		-4.17%	-5.26%

02:29pm	'HB': Sanofi plans to invest billions in Frankfurt	DP
01:56pm	ROCHE HOLDINGS AG : Deutsche Bank remains Neutral	ZD

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

'HB': Sanofi plans to invest billions in Frankfurt	08:29am	DP
BioPharma Credit to Provide Additional Funding to LumiraDx Amid Roche Deal	03:20am	MT
Swiss Market Index Closes Little Changed Amid Key European Inflation Data	06-28	MT
Roche's Eye Therapy Vabysmo Gets EU Panel's Nod for Additional Indication	06-28	MT
Roche Gets EU Panel's Backing for Rare Blood Disorder Therapy	06-28	MT
Roche's Vabysmo Wins EMA Panel's Backing for Retinal Vein Occlusion Indication	06-28	MT
Roche's Vabysmo Gets CHMP Recommendation for Third Indication Retinal Vein Occlusion	06-28	CI
Roche's Rare Blood Disorder Drug PiaSky Backed for Approval in EU	06-28	MT
Chmp Recommends EU Approval of Roche?S Piasky for People with Pnh, A Rare, Life-Threatening Blood Condition	06-28	CI
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	06-28	RE
Roche Receives Additional Prequalification Designations for HPV Test	06-27	MT
Roche Wins EU Nod for Subcutaneous Formula of Multiple Sclerosis Drug Ocrevus	06-25	MT
Halozyme Therapeutics, Inc. Announces Roche's OCREVUS SC with ENHANZE Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis	06-25	CI
Roche Announces the European Commission Grants Marketing Authorisation for OCREVUS (Ocrelizumab) Subcutaneous for the Treatment of Relapsing Multiple Sclerosis and Primary Progressive Multiple Sclerosis	06-25	CI
Global markets live: Novo Nordisk, Apple, UPS, Eli Lilly, Qualcomm...	06-24
Foreign banks target Switzerland after UBS takeover of Credit Suisse	06-24	RE
Roche: two new units for cobas pro	06-24	CF
European Medicines Agency Begins Review of Roche's Gene Therapy for Duchenne Muscular Dystrophy	06-24	MT
US FDA approves Roche's drug for a chronic blood disorder	06-21	RE
Sarepta Therapeutics Gets Expanded Label FDA Approval for Duchenne Muscular Dystrophy; Shares Soar Premarket	06-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am